Acknowledgements
MH
OAS
This study was supported by F. Hoffmann-La Roche and AbbVie. Also supported in part by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Projektnummer 467697427 (OAS), SFB 1530 project C04 (KF) B02 (CPP) and Z01/B01 (MH). Presented in parts at the 2022 annual meeting of the European Haematology Association in Vienna. We thank all the patients, their families, and their nurses and physicians for their participation in the trial. The authors thank Michele Porro Lurà and Nicola Maiorano (Basel, Switzerland) for invaluable support in the conception and conduct of the trial. We acknowledge support for the Article Processing Charge from the DFG (German Research Foundation, 491454339).